Source: Medical Device News Magazine

NEC: NEC Corporation Has Developed Technologies that Enable a Secure Workflow for Personalized Cancer Vaccines & Has Proven their Capabilities

This initiative marks a world-first accomplishment that is aligned with the practical workflow expected for personalized cancer vaccine therapies

Read full article »
Annual Revenue
$10-50B
Employees
100K-9.9M
Takayuki Morita's photo - President & CEO of NEC

President & CEO

Takayuki Morita

CEO Approval Rating

73/100

Read more